Calcium oxide or magnesium oxide production with alkali and sulfur dioxide intermediates
US-12017985-B2 · Jun 25, 2024 · US
US9422221B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9422221-B2 |
| Application number | US-201013375109-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 31, 2010 |
| Priority date | Jun 8, 2009 |
| Publication date | Aug 23, 2016 |
| Grant date | Aug 23, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A process for replacing the stabilization of (meth)acrylic monomers, wherein phenothiazine is removed from phenothiazine-containing (meth)acrylic monomers by adsorption on activated carbon, and then a moderately active polymerization inhibitor is optionally added.
Opening claim text (preview).
The invention claimed is: 1. A process for removing phenothiazine from a (meth)acrylic monomer, comprising: removing phenothiazine from a phenothiazine-containing (meth)acrylic monomer by adsorption on activated carbon, and adding a moderately active polymerization inhibitor to the (meth)acrylic monomer after adsorption, wherein the moderately active polymerization inhibitor is a phenolic compound or a quinone, wherein a content of the phenothiazine in the (meth)acrylic monomer after adsorption is less than 10 ppm. 2. The process of claim 1 , wherein a BET surface area of the activated carbon is from 200 to 3000 m 2 /g. 3. The process of claim 2 , wherein the BET surface area of the activated carbon is from 300 to 2000 m 2 /g. 4. The process of claim 1 , wherein the activated carbon is molded carbon, granular carbon or pulverized carbon. 5. The process of claim 1 , wherein the content of the phenothiazine in the (meth)acrylic monomer after adsorption is less than 5 ppm. 6. The process of claim 1 , wherein the moderately active polymerization inhibitor is hydroquinone monomethyl ether. 7. The process of claim 1 , wherein a content of moderately active polymerization inhibitor is up to 100 ppm. 8. The process of claim 1 , wherein a content of moderately active polymerization inhibitor is around 50 ppm. 9. The process of claim 1 , wherein the (meth)acrylic monomer is a (meth)acrylic acid. 10. The process of claim 9 , wherein the (meth)acrylic monomer is an acrylic acid. 11. The process of claim 10 , wherein a water content of the acrylic acid is from 40 to 75% by weight. 12. The process of claim 10 , wherein the acrylic acid is anhydrous. 13. The process of claim 10 , wherein from 20 to 95 mol % of acid groups of the acrylic acid are neutralized. 14. The process of claim 10 , wherein acid groups of the acrylic acid are unneutralized. 15. The process of claim 10 , wherein from 40 to 75 mol % of acid groups of the acrylic acid are neutralized. 16. The process of claim 10 , further comprising: polymerizing the acrylic acid after adsorption, to obtain a superabsorbent polymer. 17. The process of claim 1 , wherein removing phenothiazine comprises a fixed bed process. 18. The process of claim 1 , further comprising regenerating the activated carbon.
Related publications grouped by family.
Answers are generated from the same data shown on this page.